PEGylation of lipophilic SN38 prodrug with DSPE-mPEG₂₀₀₀ versus cremophor EL: comparative study for intravenous chemotherapy

References

• Bala V, Rao S, Bateman E, et al. (2016). Enabling oral sn38-based chemotherapy with a combined lipophilic prodrug and self-microemulsifying drug delivery system. Mol Pharm 13:3518–25.
   PubMed Web of Science ®Google Scholar
• Barenholz Y. (2012). Doxil®-the first FDA-approved nano-drug: lessons learned. J Control Release 160:117–34.
   PubMed Web of Science ®Google Scholar
• Bedikian AY, DeConti RC, Conry R, et al. (2011). Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma. Ann Oncol 22:787–93.
   PubMed Web of Science ®Google Scholar
• Bradley MO, Swindell CS, Anthony FH, et al. (2001a). Tumor targeting by conjugation of DHA to paclitaxel. J Control Release 74:233–6.
   PubMed Web of Science ®Google Scholar
• Bradley MO, Webb NL, Anthony FH, et al. (2001b). Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel. Clin Cancer Res 7:3229–38.
   PubMed Web of Science ®Google Scholar
• Cabral H, Matsumoto Y, Mizuno K, et al. (2011). Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nature Nanotech 6:815–23.,
   PubMed Web of Science ®Google Scholar
• Dosio F, Reddy LH, Ferrero A, et al. (2010). Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation. Bioconjugate Chem 21:1349–61.
   PubMed Web of Science ®Google Scholar
• Gelderblom H, Verweij J, Nooter K, et al. (2001). Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37:1590–8.
   PubMed Web of Science ®Google Scholar
• Hou M, Gao YE, Shi X, et al. (2018). Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy. Acta Biomaterialia 77:228–39.
   PubMed Web of Science ®Google Scholar
• Kastantin M, Missirlis D, Black M, et al. (2010). Thermodynamic and kinetic stability of DSPE-PEG(2000) micelles in the presence of bovine serum albumin. J Phys Chem B 114:12632–40.
   PubMed Web of Science ®Google Scholar
• Ke XY, Zhao BJ, Zhao X, et al. (2010). The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat. Biomaterials 31:5855–64.
   PubMed Web of Science ®Google Scholar
• Li Y, Kang T, Wu Y, et al. (2018). Carbonate esters turn camptothecin-unsaturated fatty acid prodrugs into nanomedicines for cancer therapy. Chem Commun 54:1996–9.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu J, Kang T, et al. (2018). Co-assembling FRET nanomedicine with self-indicating drug release. Chem Commun (Camb) 54:11618–21.
   PubMed Web of Science ®Google Scholar
• Liu X, Huang Q, Yang C, et al. (2017). A multi-stimuli responsive nanoparticulate SN38 prodrug for cancer chemotherapy. J Mater Chem B 5:661–70.
   PubMed Web of Science ®Google Scholar
• Lundberg BB. (2011). Preparation and characterization of polymeric pH-sensitive STEALTH (R) nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel. Int J Pharm 408:208–12.
   PubMed Web of Science ®Google Scholar
• Luo C, Sun J, Liu D, et al. (2016). Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy. Nano Lett 16:5401–8.
   PubMed Web of Science ®Google Scholar
• Luo C, Sun J, Sun B, et al. (2016). Facile fabrication of tumor redox-sensitive nanoassemblies of small-molecule oleate prodrug as potent chemotherapeutic nanomedicine. Small 12:6353–62.
   PubMed Web of Science ®Google Scholar
• Owen SC, Chan DPY, Shoichet MS. (2012). Polymeric micelle stability. Nano Today 7:53–65.
   Web of Science ®Google Scholar
• Rabinow B, Kipp J, Papadopoulos P, et al. (2007). Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int J Pharm 339:251–60.
   PubMed Web of Science ®Google Scholar
• Ren G, Liu D, Guo W, et al. (2016). Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation. Drug Deliv 23:1272–81.
   PubMed Web of Science ®Google Scholar
• Sun B, Luo C, Yu H, et al. (2018). Disulfide bond-driven oxidation- and reduction-responsive prodrug nanoassemblies for cancer therapy. Nano Lett 18:3643–50.
   PubMed Web of Science ®Google Scholar
• Wang H, Lu Z, Wang L, et al. (2017). New generation nanomedicines constructed from self-assembling small-molecule prodrugs alleviate cancer drug toxicity. Cancer Res 77:6963–74.
   PubMed Web of Science ®Google Scholar
• Wang H, Xie H, Wang J, et al. (2015). Self-assembling prodrugs by precise programming of molecular structures that contribute distinct stability, pharmacokinetics, and antitumor efficacy. Adv Funct Mater 25:4956–65.
   Web of Science ®Google Scholar
• Wang J, Mao W, Lock LL, et al. (2015). The role of micelle size in tumor accumulation, penetration, and treatment. ACS Nano 9:7195–206.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu D, Zheng Q, et al. (2014). Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines. Nano Lett 14:5577–83.
   PubMed Web of Science ®Google Scholar
• Wisse E, Jacobs F, Topal B, et al. (2008). The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther 15:1193–9.
   PubMed Web of Science ®Google Scholar
• Wolff AC, Donehower RC, Carducci MK, et al. (2003). Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile. Clin Cancer Res 9:3589–97.
   PubMed Web of Science ®Google Scholar
• Zhang H, Xu W, Omari-Siaw E, et al. (2017a). Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy. Drug Deliv 24:1170–8.
   PubMed Web of Science ®Google Scholar
• Zhang S, Guan J, Sun M, et al. (2017b). Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy. Drug Deliv 24:1460–9.
   PubMed Web of Science ®Google Scholar
• Zhang W, Lin W, Pei Q, et al. (2016). Redox-hypersensitive organic nanoparticles for selective treatment of cancer cells. Chem Mater 28:4440–6.
   Web of Science ®Google Scholar
• Zhang Y, Teh C, Li M, et al. (2016). Acid-responsive polymeric doxorubicin prodrug nanoparticles encapsulating a near-infrared dye for combined photothermal-chemotherapy. Chem Mater 28:7039–50.
   Web of Science ®Google Scholar
• Zheng Y, Yan X, Wang Y, et al. (2019). Hydrophobized SN38 to redox-hypersensitive nanorods for cancer therapy. J Mater Chem B 7:265–76.
   PubMed Web of Science ®Google Scholar
• Zhong T, Hao YL, Yao X, et al. (2018). Effect of XlogP and Hansen solubility parameters on small molecule modified paclitaxel anticancer drug conjugates self-assembled into nanoparticles. Bioconjugate Chem 29:437–44.
   PubMed Web of Science ®Google Scholar
• Zhong T, Yao X, Zhang S, et al. (2016). A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic. Sci Rep 6: 36614.
   PubMed Web of Science ®Google Scholar